DBVT FY 2018 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+11.3% YoY

Gross Profit

$13M100.0% margin

Operating Income

-$190M-1483.6% margin

Net Income

-$190M-1484.7% margin

EPS (Diluted)

$-39.25

Cash Flow

Operating Cash Flow

-$187M

Free Cash Flow

-$193M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$235M

Total Liabilities

$69M

Stockholders' Equity

$166M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$12M	+11.3%
Gross Profit	$13M	$12M	+11.3%
Operating Income	-$190M	-$174M	-9.3%
Net Income	-$190M	-$177M	-7.4%